新天然氣(603393.SH)高管王彬因病逝世終止減持計劃 尚未減持股份
格隆匯10月24日丨新天然氣(603393.SH)公佈,截止減持計劃披露前,公司董事、監事、高級管理人員王彬合計持有公司無限售流通股股份101.92萬股,佔公司總股本的0.46%。
自減持計劃公告披露之日起15個交易日後的六個月內,王彬擬通過上海證券交易系統以集中競價交易的方式減持公司股票,減持股數不超過25萬股,佔公司總股本的0.11%,佔其持有公司股份的24.53%,減持價格視市場價格確定。
截至本公告披露日,王彬未進行減持,王彬已於2019年8月21日辭去公司第三屆董事會祕書及副總經理職務。近日王彬因病逝世,本次減持股份計劃終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.